As of recent estimates, the global market for reagents used in Next-Generation Sequencing (NGS) is significant. In 2023, the market for NGS reagents was valued at approximately $2.5 billion to $3 billion annually. This includes a range of reagents and consumables such as sequencing kits, libraries, and other materials required for NGS processes.

The NGS reagent market is driven by…

What are the top bioinformatics concerns for researchers that perform next-generation sequencing? We wanted to understand their “top of mind” concerns and not prompt users with a list of potential answers from which to choose.  So, we asked over 400 scientists in government, private, commercial and academic labs in the United States, all involved in performing next generation sequencing,…

The Kaiser Permanente Center for Health Research was awarded $8.1 million from the National Institutes of Health (NIH) to conduct a novel clinical trial using whole genome sequencing to test women and their partners, before they actually conceive, for mutations that could cause rare, but serious diseases in their offspring.

The project is part of the Clinical Sequencing Exploratory Research…